What should you know about RSV and who can get it? In many cases, there is a difference for adults and children, ...
Respiratory syncytial virus is a common, highly contagious illness that often causes mild upper respiratory symptoms, akin to a cold. In babies, particularly those with tiny airways, RSV can cause the ...
The panel of vaccine experts were supposed to hold their first meeting under the Trump administration in late February. It's ...
If it seems like you and everyone around you are getting sick this winter, you're not wrong. The surge in flu cases also comes amid concerns about high infection rates for other viruses including ...
According to the CDC, every year between 60,000 and 160,000 older Americans are hospitalized for RSV, and approximately 6,000 to 10,000 people die from the virus. RSV typically begins in the fall ...
When existing systems do not accommodate access to health care innovation, we must change those systems. Fulfilling nirsevimab’s promise will require overcoming entrenched hospital payment norms.
A cohort study found that nearly three fourths of infants received respiratory syncytial virus protection with either nirsevimab or through exposure to maternal RSVpreF in the 2023-2024 season.
CDC director Mandy Cohen said the drug "provides parents with a powerful tool to protect their children against the threat of RSV", which, according to agency data, hospitalises somewhere between ...
Officials at East Liverpool City Hospital are reporting a significant rise in Influenza A, as well as cases of RSV this ...
Last night, the CDC’s Advisory Committee on Immunisation Practices (ACIP) voted in favour of making both vaccines available to this age group ahead of the next RSV season, which typically starts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results